

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Pathophysiology and treatment of patients with... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2156/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2156" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Pathophysiology and treatment of patients with beta-thalassemia – an update" />
    
            <meta name="og:title" content="F1000Research Article: Pathophysiology and treatment of patients with beta-thalassemia &ndash; an update.">
            <meta name="og:description" content="Read the latest article version by Eitan Fibach, Eliezer A. Rachmilewitz, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13741">
            <meta name="article-id" content="12688">
            <meta name="dc.title" content="Pathophysiology and treatment of patients with beta-thalassemia &ndash; an update">
            <meta name="dc.description" content="Thalassemia (thal) is an autosomal recessive, hereditary, chronic hemolytic anemia due to a partial or complete deficiency in the synthesis of &alpha;-globin chains (&alpha;-thal) or &beta;-globin chains (&beta;-thal) that compose the major adult hemoglobin (&alpha; 2 &beta; 2). It is caused by one or more mutations in the corresponding genes. The unpaired globin chains are unstable; they precipitate intracellularly, resulting in hemolysis, premature destruction of red blood cell [RBC] precursors in the bone marrow, and a short life-span of mature RBCs in the circulation. The state of anemia is treated by frequent RBC transfusions. This therapy results in the accumulation of iron (iron overload), a condition that is exacerbated by the breakdown products of hemoglobin (heme and iron) and the increased iron uptake for the chronic accelerated, but ineffective, RBC production. Iron catalyzes the generation of reactive oxygen species, which in excess are toxic, causing damage to vital organs such as the heart and liver and the endocrine system. 
Herein, we review recent findings regarding the pathophysiology underlying the major symptoms of &beta;-thal and potential therapeutic modalities for the amelioration of its complications, as well as new modalities that may provide a cure for the disease.">
            <meta name="dc.subject" content="Thalessemia, hemolytic anemia, &beta;-globin ">
            <meta name="dc.creator" content="Fibach, Eitan">
            <meta name="dc.creator" content="Rachmilewitz, Eliezer A.">
            <meta name="dc.date" content="2017/12/20">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12688.1">
            <meta name="dc.source" content="F1000Research 2017 6:2156">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Thalessemia">
            <meta name="prism.keyword" content="hemolytic anemia">
            <meta name="prism.keyword" content="&beta;-globin ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/12/20">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2156">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12688.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2156">
            <meta name="citation_title" content="Pathophysiology and treatment of patients with beta-thalassemia &ndash; an update">
            <meta name="citation_abstract" content="Thalassemia (thal) is an autosomal recessive, hereditary, chronic hemolytic anemia due to a partial or complete deficiency in the synthesis of &alpha;-globin chains (&alpha;-thal) or &beta;-globin chains (&beta;-thal) that compose the major adult hemoglobin (&alpha; 2 &beta; 2). It is caused by one or more mutations in the corresponding genes. The unpaired globin chains are unstable; they precipitate intracellularly, resulting in hemolysis, premature destruction of red blood cell [RBC] precursors in the bone marrow, and a short life-span of mature RBCs in the circulation. The state of anemia is treated by frequent RBC transfusions. This therapy results in the accumulation of iron (iron overload), a condition that is exacerbated by the breakdown products of hemoglobin (heme and iron) and the increased iron uptake for the chronic accelerated, but ineffective, RBC production. Iron catalyzes the generation of reactive oxygen species, which in excess are toxic, causing damage to vital organs such as the heart and liver and the endocrine system. 
Herein, we review recent findings regarding the pathophysiology underlying the major symptoms of &beta;-thal and potential therapeutic modalities for the amelioration of its complications, as well as new modalities that may provide a cure for the disease.">
            <meta name="citation_description" content="Thalassemia (thal) is an autosomal recessive, hereditary, chronic hemolytic anemia due to a partial or complete deficiency in the synthesis of &alpha;-globin chains (&alpha;-thal) or &beta;-globin chains (&beta;-thal) that compose the major adult hemoglobin (&alpha; 2 &beta; 2). It is caused by one or more mutations in the corresponding genes. The unpaired globin chains are unstable; they precipitate intracellularly, resulting in hemolysis, premature destruction of red blood cell [RBC] precursors in the bone marrow, and a short life-span of mature RBCs in the circulation. The state of anemia is treated by frequent RBC transfusions. This therapy results in the accumulation of iron (iron overload), a condition that is exacerbated by the breakdown products of hemoglobin (heme and iron) and the increased iron uptake for the chronic accelerated, but ineffective, RBC production. Iron catalyzes the generation of reactive oxygen species, which in excess are toxic, causing damage to vital organs such as the heart and liver and the endocrine system. 
Herein, we review recent findings regarding the pathophysiology underlying the major symptoms of &beta;-thal and potential therapeutic modalities for the amelioration of its complications, as well as new modalities that may provide a cure for the disease.">
            <meta name="citation_keywords" content="Thalessemia, hemolytic anemia, &beta;-globin ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Eitan Fibach">
            <meta name="citation_author_institution" content="Department of Hematology, Hadassah &ndash; Hebrew University Medical Center, Jerusalem, Israel">
            <meta name="citation_author" content="Eliezer A. Rachmilewitz">
            <meta name="citation_author_institution" content="Department of Hematology, The Edith Wolfson Medical Center, Holon, Israel">
            <meta name="citation_publication_date" content="2017/12/20">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2156">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12688.1">
            <meta name="citation_firstpage" content="2156">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2156/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2156.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13741 /> <input type=hidden id=articleId name=articleId value=12688 /> <input type=hidden id=xmlUrl value="/articles/6-2156/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2156-v1.xml"> <input type=hidden id=article_uuid value=d31e704d-3611-44c1-9683-68564845baf1 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Pathophysiology and treatment of patients with beta-thalassemia – an update"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12688.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12688.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2156"
  },
  "headline": "Pathophysiology and treatment of patients with beta-thalassemia – an update",
  "datePublished": "2017-12-20T15:07:43",
  "dateModified": "2017-12-20T15:07:43",
  "author": [
    {
      "@type": "Person",
      "name": "Eitan Fibach"
    },    {
      "@type": "Person",
      "name": "Eliezer A. Rachmilewitz"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Thalassemia (thal) is an autosomal recessive, hereditary, chronic hemolytic anemia due to a partial or complete deficiency in the synthesis of &alpha;-globin chains (&alpha;-thal) or &beta;-globin chains (&beta;-thal) that compose the major adult hemoglobin (&alpha;2&beta;2). It is caused by one or more mutations in the corresponding genes. The unpaired globin chains are unstable; they precipitate intracellularly, resulting in hemolysis, premature destruction of red blood cell [RBC] precursors in the bone marrow, and a short life-span of mature RBCs in the circulation. The state of anemia is treated by frequent RBC transfusions. This therapy results in the accumulation of iron (iron overload), a condition that is exacerbated by the breakdown products of hemoglobin (heme and iron) and the increased iron uptake for the chronic accelerated, but ineffective, RBC production. Iron catalyzes the generation of reactive oxygen species, which in excess are toxic, causing damage to vital organs such as the heart and liver and the endocrine system.
Herein, we review recent findings regarding the pathophysiology underlying the major symptoms of &beta;-thal and potential therapeutic modalities for the amelioration of its complications, as well as new modalities that may provide a cure for the disease."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2156.html",
            "name": "Pathophysiology and treatment of patients with beta-thalassemia –..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Pathophysiology and treatment of patients with beta-thalassemia –... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13741 data-id=12688 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12688.1" data-recommended="" data-doi="10.12688/f1000research.12688.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2156/v1/pdf?article_uuid=d31e704d-3611-44c1-9683-68564845baf1" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12688-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12688-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12688-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Fibach E and Rachmilewitz EA. Pathophysiology and treatment of patients with beta-thalassemia – an update [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2156 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12688.1" target=_blank>https://doi.org/10.12688/f1000research.12688.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12688-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12688 id=track-article-signin-12688 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12688?target=/articles/6-2156.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13741 /> <input name=articleId type=hidden value=12688 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Pathophysiology and treatment of patients with beta-thalassemia – an update</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:fibach@yahoo.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Eitan Fibach</span></a><a href="https://orcid.org/0000-0002-6658-6126" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6658-6126</div><sup>1</sup>,&nbsp;</span><span class="">Eliezer A. Rachmilewitz<sup>2</sup><sup>+</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:fibach@yahoo.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Eitan Fibach</span></a><a href="http://orcid.org/0000-0002-6658-6126" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6658-6126</div><sup>1</sup>,&nbsp;</span><span class="">Eliezer A. Rachmilewitz<sup>2</sup><sup>+</sup></span></div> </div> <div class="authors extra-info"> <sup>+</sup> Deceased author </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 20 Dec 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12688.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Hematology, Hadassah &ndash; Hebrew University Medical Center, Jerusalem, Israel<br/> <sup>2</sup> Department of Hematology, The Edith Wolfson Medical Center, Holon, Israel<br/> <p> <div class=margin-bottom> Eitan Fibach <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Eliezer A. Rachmilewitz <br/> <span>Roles: </span> Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28997-29001></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28998-29002></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Thalassemia (thal) is an autosomal recessive, hereditary, chronic hemolytic anemia due to a partial or complete deficiency in the synthesis of α-globin chains (α-thal) or β-globin chains (β-thal) that compose the major adult hemoglobin (α<sub>2</sub>β<sub>2).</sub> It is caused by one or more mutations in the corresponding genes. The unpaired globin chains are unstable; they precipitate intracellularly, resulting in hemolysis, premature destruction of red blood cell [RBC] precursors in the bone marrow, and a short life-span of mature RBCs in the circulation. The state of anemia is treated by frequent RBC transfusions. This therapy results in the accumulation of iron (iron overload), a condition that is exacerbated by the breakdown products of hemoglobin (heme and iron) and the increased iron uptake for the chronic accelerated, but ineffective, RBC production. Iron catalyzes the generation of reactive oxygen species, which in excess are toxic, causing damage to vital organs such as the heart and liver and the endocrine system.<br/> Herein, we review recent findings regarding the pathophysiology underlying the major symptoms of β-thal and potential therapeutic modalities for the amelioration of its complications, as well as new modalities that may provide a cure for the disease. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Thalessemia, hemolytic anemia, β-globin </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Eitan Fibach (<a href="mailto:fibach@yahoo.com">fibach@yahoo.com</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Eitan Fibach </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Fibach E and Rachmilewitz EA. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Fibach E and Rachmilewitz EA. Pathophysiology and treatment of patients with beta-thalassemia – an update [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2156 (<a href="https://doi.org/10.12688/f1000research.12688.1" target=_blank>https://doi.org/10.12688/f1000research.12688.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 20 Dec 2017, <b>6</b>(F1000 Faculty Rev):2156 (<a href="https://doi.org/10.12688/f1000research.12688.1" target=_blank>https://doi.org/10.12688/f1000research.12688.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 20 Dec 2017, <b>6</b>(F1000 Faculty Rev):2156 (<a href="https://doi.org/10.12688/f1000research.12688.1" target=_blank>https://doi.org/10.12688/f1000research.12688.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e177>Introduction</h2><p class="" id=d6442e180>Thalassemia (thal) is an autosomal recessive hereditary chronic hemolytic anemia due to a partial or complete deficiency in the synthesis of α-globin chains (α-thal) or β-globin chains (β-thal) which compose the major adult hemoglobin (HbA), a tetramer of α<sub>2</sub>β<sub>2</sub>. It is caused by one or more of several hundred mutations in the corresponding genes. The unpaired globin chains are unstable; they precipitate intracellularly, resulting in hemolysis, premature destruction (by apoptosis) of red blood cell (RBC) precursors in the bone marrow, and a short life-span of mature RBCs in the circulation. The breakdown products of Hb, heme and iron, catalyze chemical reactions that generate free radicals, including reactive oxygen species (ROS), which in excess are toxic, causing damage to vital organs such as the heart and liver and the endocrine system<sup><a href="#ref-1">1</a></sup>.</p><p class="" id=d6442e193>Thalassemia is the most common monogenic inherited disease worldwide. Historically, it originated and spread around the Mediterranean, the Middle East, and Southeast Asia, coincidental with the occurrence of malaria (carriers of the thal genes are considered to be resistant to the malaria parasite)<sup><a href="#ref-2">2</a></sup>. Today, because of vast migration, thal patients are present around the globe<sup><a href="#ref-3">3</a></sup> and their incidence increases steadily.</p><p class="" id=d6442e204>Beta-thal is classified into three main subgroups based on their clinical expression: major, intermedia, and minor. β-thal major presents itself within the first 2 years of life with severe anemia, poor growth, and skeletal abnormalities and requires regular, lifelong blood transfusions. β-thal intermedia requires only periodic blood transfusions, while β-thal minor does not require a specific treatment. Alpha-thal presents with moderate anemia when there is a significant lack of synthesis of α-globin chains (HbH disease).</p><p class="" id=d6442e207>There are several combinations of β-thal with other diseases associated with abnormal β-globin, such as HbE and HbS (sickle cell disease) that can be expressed clinically with severe anemia. A combination of β-thal with α-thal results in a milder disease, most likely owing to the less severe α:β imbalance<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d6442e215>Thanks to the significant improvement in therapy, patients with β-thal may reach an advanced age. This is associated with clinical symptoms that are the consequence of the disease itself and the treatment modalities.</p><p class="" id=d6442e218>Herein, we review recent findings regarding the pathophysiology underlying the major symptoms of β-thal and potential therapeutic modalities for the amelioration of its complications, as well as new modalities that may provide a cure for the disease.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e224>Chronic anemia – RBC transfusions</h2><p class="" id=d6442e227>The basic clinical symptom of β-thal is chronic anemia—reduced number of RBCs and their Hb content, resulting from deficiency in Hb production and hemolysis. Chronic anemia is treated by RBC transfusion—in severe cases, every 2 weeks—which affects the patient’s quality of life, may cause recurrent infections and immune reactions, and—above all—iron overload (IO). Iron deposition in vital organs, through the generation of ROS, is a major cause of morbidity and mortality, especially among elderly patients<sup><a href="#ref-5">5</a></sup>.</p><p class="" id=d6442e234>Potential developments in the field of transfusion (beyond the scope of this review) include, among others, conditions of storage<sup><a href="#ref-6">6</a></sup>, <i>ex vivo</i> production of stem cell-derived RBCs<sup><a href="#ref-7">7</a></sup>, and transfusion of cell-free Hb<sup><a href="#ref-8">8</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e255>Iron overload</h2><p class="" id=d6442e258>The iron status reflects the balance among dietary iron uptake, its storage and mobilization, and its utilization. Iron overload is a common and serious problem in thal<sup><a href="#ref-9">9</a></sup>, as well as in other hereditary and acquired hemolytic anemias<sup><a href="#ref-10">10</a></sup>. The main causes of IO in thal are Hb instability, RBC transfusions, and increased iron absorption from the gastrointestinal tract.</p><p class="" id=d6442e269>Normally, 1–2 mg of iron is absorbed from the diet per day, with an equivalent amount lost by the turnover of gastrointestinal tract epithelial cells. The body has no mechanism for disposing of excess iron<sup><a href="#ref-11">11</a></sup>; therefore, in thal and other transfusion-dependent anemias, IO may accumulate in a relatively short time (transfusional IO). An RBC transfusion requirement of two units (200–250 mg of iron per unit) per month will result in over 20 g of excess body iron in 4 years<sup><a href="#ref-12">12</a></sup>.</p><p class="" id=d6442e280>Most of the iron in the body is bound to other molecules. In the plasma, it is bound to transferrin<sup><a href="#ref-13">13</a></sup>. When the transferrin iron-binding capacity is saturated (&gt;80%), non-transferrin-bound iron (NTBI) forms appear<sup><a href="#ref-14">14</a></sup>. Most of the iron gets into cells through their surface transferrin receptor (TfR1)<sup><a href="#ref-15">15</a></sup>, but a small fraction is taken up by non-transferrin pathways<sup><a href="#ref-16">16</a></sup>. In erythroid cells, the incoming iron is mainly incorporated into heme to form the Hb molecule or is stored in ferritin<sup><a href="#ref-17">17</a></sup>. A small fraction remains free or loosely bound to other compounds as the labile iron pool (LIP)<sup><a href="#ref-18">18</a></sup>. The LIP has been suggested as a low-molecular-weight intermediate or transitory pool between extracellular iron and intracellular firmly bound iron<sup><a href="#ref-19">19</a></sup>. The intracellular LIP is redox active, catalyzing the Fenton and Haber-Weiss reactions that generate ROS<sup><a href="#ref-20">20</a></sup>. Excess ROS are cytotoxic through their interaction with cellular components, such as DNA, proteins, and lipids, causing damage to vital organs<sup><a href="#ref-21">21</a></sup>.</p><div class=section><a name=d6442e320 class=n-a></a><h3 class=section-title>Removal of excess iron</h3><p class="" id=d6442e325>Repeated bleeding (phlebotomy) is used to remove excess iron in patients with normal Hb levels, such as in patients with hereditary hemochromatosis, where IO is caused by mutations in the iron homeostasis system<sup><a href="#ref-22">22</a></sup>. Patients after hematopoietic stem cell (HSC) transplantation (HSCT) who had IO prior to transplantation due to multiple transfusions may also benefit from this treatment<sup><a href="#ref-23">23</a></sup>.</p><p class="" id=d6442e336>Most other IO patients are anemic (Hb &lt;10 g/dL) and, therefore, particularly those who are transfusion dependent, will require iron chelation therapy in order to normalize their iron level (a transferrin saturation of &lt;50% and serum ferritin &lt;500 ng/mL). Iron chelators remove excess iron from the plasma and the cells by binding the labile, chelatable iron, thus facilitating its excretion through the urine and feces.</p><p class="" id=d6442e339>Three iron chelators are currently in clinical use. Deferoxamine, the first to be used clinically, is given by a slow, continuous, subcutaneous, overnight infusion through a portable pump. While its side effects are minimal, its mode of administration results in low compliance<sup><a href="#ref-24">24</a></sup>. Deferasirox, the first effective oral chelator, is given at 20–30 mg/kg once/day. Adverse effects (occurring in approximately 10% of patients) include nausea, abdominal pain, diarrhea, and rash as well as liver and kidney dysfunction. A new formulation of film-coated tablets provides better patient compliance, since it can be swallowed with a light meal without the need to disperse the tablet into a suspension prior to consumption<sup><a href="#ref-25">25</a></sup>. Deferiprone is an oral iron chelator effective in removing excess iron from the organs and mainly from the heart. The main potential complication is neutropenia that may rarely be followed by agranulocytosis. A liquid formulation has been recently introduced<sup><a href="#ref-26">26</a></sup>.</p><p class="" id=d6442e354>The efficacy of chelation may be improved by the use of a combination of chelators. Thus, deferiprone may mobilize iron from tissues into the circulation, where deferoxamine binds and facilitates its excretion in the urine (the “shuttle mechanism”)<sup><a href="#ref-27">27</a></sup>.</p><p class="" id=d6442e362>An additional potential approach to reduce iron load, especially NTBI, is the administration of exogenous iron-free (apo)transferrin through the down regulation of TfR1<sup><a href="#ref-28">28</a></sup>.</p><p class="" id=d6442e369>In addition to free iron, some iron-containing compounds that are elevated in the plasma of thal patients due to hemolysis, such as free hemin and Hb, are of considerable toxicity. These compounds are neutralized by their scavengers, hemopexin and haptoglobin, respectively. In thal, these proteins are reduced, leaving free, un-neutralized hemin and Hb. The administration of hemopexin/haptoglobin may be suggested to reduce iron toxicity<sup><a href="#ref-29">29</a></sup>.</p></div><div class=section><a name=d6442e378 class=n-a></a><h3 class=section-title>Modulation of iron absorption</h3><p class="" id=d6442e383>Iron homeostasis is tightly regulated, mainly by hepcidin, a 25-amino-acid peptide which inhibits iron absorption and distribution. It binds to ferroportin, a surface iron exporter on absorptive enterocytes, macrophages, hepatocytes, and placenta cells. This binding induces ferroportin to be internalized and degraded, decreasing, consequently, the export of iron from these cells<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d6442e390>The level of hepcidin depends mainly on its rate of production in the liver, which is modulated mainly by the iron status and requirement. Iron loading increases hepcidin production, resulting in reduced intestinal iron absorption while iron deficiency has an opposite effect<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d6442e397>In β-thal, in spite of IO, hepcidin production is generally low, and consequently iron absorption is high<sup><a href="#ref-31">31</a></sup>. The reason for this anomaly is the inhibition of hepcidin gene expression caused by two factors. (A) High iron demand by the chronic stress erythropoiesis (see below)<sup><a href="#ref-32">32</a></sup>. Soluble factors such as the growth differentiation factor (GDF)-15<sup><a href="#ref-33">33</a></sup>, twisted gastrulation protein homolog 1<sup><a href="#ref-34">34</a></sup>, soluble transferrin receptor<sup><a href="#ref-35">35</a></sup>, and erythroferrone<sup><a href="#ref-36">36</a></sup>, which are overproduced by the proliferating erythroid precursors, inhibit hepcidin expression. (B) Oxidative stress (see below) due to the inactivation of transcription factors, including CCAAT/enhancer-binding protein a (C/EBPa) and signal transducer and activator of transcription 3 (STAT3)<sup><a href="#ref-37">37</a></sup>, histone deacetylase activation<sup><a href="#ref-38">38</a></sup>, and hypoxia-inducible factors<sup><a href="#ref-39">39</a></sup>. The decrease in hepcidin production is, however, balanced by other conditions prevalent in β-thal, including blood transfusions and inflammation that increase hepcidin production. In the latter case, pro-inflammatory cytokines, such as interleukins 6 and 1, turn on the hepcidin gene promoter by activating the STAT3 pathway<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d6442e441>Administration of hepcidin or stimulating its expression could improve IO by decreasing iron absorption. This was demonstrated in murine models of β-thal intermedia by (A) minihepcidins, small peptides that mimic hepcidin activity and act as agonists<sup><a href="#ref-41">41</a></sup>, (B) inhibition of negative regulators of matriptase-2 (TMPRSS6), a key regulator of hepcidin production, with silencing RNAs or antisense oligonucleotides<sup><a href="#ref-42">42</a></sup>, (C) exogenous transferrin through downregulation of TfR1<sup><a href="#ref-28">28</a></sup>, and (D) inhibition of erythroferrone<sup><a href="#ref-43">43</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e464>Dyserythropoiesis</h2><p class="" id=d6442e467>The chronic anemia and its associated hypoxia in thal stimulate increased production of RBCs (chronic stress erythropoiesis). This is mediated by overproduction of erythropoietin (EPO), the main erythropoietic stimulating hormone, and other factors, such as members of the transforming growth factor (TGF)-β and activin receptor-II (ActR-II) trap ligands<sup><a href="#ref-44">44</a></sup>. Binding of EPO to its surface receptor on erythroid precursors activates transduction pathways, including Jak2/Stat5, which inhibit apoptosis and induce proliferation and differentiation of the developing cells. However, this attempt is futile (“ineffective erythropoiesis”) due to oxidative stress-increased apoptosis and abortive differentiation.</p><p class="" id=d6442e474>Several therapeutic modalities aimed at reducing the dysery-thropoiesis in thal are currently under study and described below.</p><div class=section><a name=d6442e477 class=n-a></a><h3 class=section-title>Activin receptor-II trap ligands</h3><p class="" id=d6442e482>Luspatercept and Sotatercept, compounds that bind to trap ligands and GDF-11, developed in animal models, are currently in clinical trials<sup><a href="#ref-44">44</a></sup>. They prevent activins binding to ActR-II and the activation of the Smad 4-dependent signaling pathway, improving erythroid maturation and RBC production. A phase 3, multicenter, multinational study with luspatercept is ongoing in β-thal and HbE/β-thal subjects, with encouraging preliminary results<sup><a href="#ref-45">45</a></sup>.</p></div><div class=section><a name=d6442e494 class=n-a></a><h3 class=section-title>JAK2 inhibitors</h3><p class="" id=d6442e499>The EPO signaling of erythropoiesis involves Jak2 phosphorylation. Beta-thal mice have elevated EPO levels associated with increased Jak2 phosphorylation, resulting in ineffective erythropoiesis and extramedullary hematopoiesis<sup><a href="#ref-46">46</a></sup>. Jak2 inhibitors effectively reduce splenomegaly in such mice. Several Jak2 inhibitors have been developed with beneficial results in patients with myelofibrosis and Jak2-related polycythemia vera<sup><a href="#ref-47">47</a></sup>. Jak2 inhibitors could be also beneficial for non-transfusion-dependent thal patients with splenomegaly<sup><a href="#ref-48">48</a></sup>.</p></div><div class=section><a name=d6442e516 class=n-a></a><h3 class=section-title>Induction of the Hsp70 chaperone machinery</h3><p class="" id=d6442e521>The heat shock protein 70 (Hsp70) is a molecular chaperone needed for normal termination of erythropoiesis<sup><a href="#ref-49">49</a></sup>. It is predominant in the late erythroid precursors when it is translocated to the nucleus and protects the globin transcription factor-1 (GATA-1), the principal transcriptional factor for erythropoiesis, from caspase-3 cleavage<sup><a href="#ref-50">50</a></sup>. In β-thal major, HSP70 is sequestrated in the cytoplasm, leaving GATA-1 unprotected from cleavage, resulting in end-stage maturation arrest and apoptosis<sup><a href="#ref-51">51</a></sup>. Exportins, such as XPO1, are factors that control the nucleocytoplasmic trafficking of proteins and RNAs. The XPO1 inhibitors leptomycin B and KPT 251, recently tested in erythroid progenitors from β-thal major patients, demonstrated induction of HSP70 nuclear localization, GATA-1 expression, and improved terminal erythroid differentiation<sup><a href="#ref-52">52</a></sup>.</p></div><div class=section><a name=d6442e541 class=n-a></a><h3 class=section-title>Reducing α-globin synthesis</h3><p class="" id=d6442e546>The key pathophysiological mechanism leading to the ineffective erythropoiesis in β-thal is the continuous production and accumulation of free excess α-globin in the erythroid precursors. Indeed, reduction in α-globin chain output through co-inheritance of α-thal ameliorates the disease phenotype in patients with β-thal<sup><a href="#ref-53">53</a></sup>. The challenge here is selective silencing of the α-globin expression to an appropriate degree to be useful for patients with β-thal<sup><a href="#ref-54">54</a></sup>. Plausible approaches include post-transcriptional silencing through RNA interference (RNAi) using small interfering RNAs, short hairpin RNA, epigenetic drug targeting to alter the chromatin environment of the α-globin genes, and genome editing to disrupt the expression of the α-globin genes<sup><a href="#ref-55">55</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e565>Oxidative stress</h2><p class="" id=d6442e568>Although oxidative stress is not the primary etiology of thal, it plays a major role in its pathophysiology. The oxidative status of cells is regulated by the equilibrium between oxidants, such as the reactive oxygen species (ROS) that are produced mainly as byproducts of cellular respiration, and anti-oxidants, such as reduced glutathione. A balanced oxidative state is crucial for normal physiology. ROS serve as regulators in many processes, including proliferation and differentiation of the erythroid precursors. When this balance fails, such as in many pathological processes, oxidative stress ensues. The excess ROS bind to cell components such as the DNA, proteins, and membrane lipids, leading to cytotoxicity<sup><a href="#ref-21">21</a></sup>. In β-thal, oxidative stress is mainly the consequence of the unstable Hbs (hemichromes) and IO and it mediates many of its symptoms due to oxidative damage to RBCs (anemia), platelets, (hypercoagulable state) and leukocytes (recurrent infections) as well as cells in various vital organs (heart and liver) and the endocrine glands<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d6442e579>Oxidative stress may be ameliorated by endogenous and exogenous antioxidants. Their effects include scavenging and inactivating ROS and correcting their damage to cellular components. Many antioxidants are supplied by nutrition. A "Mediterranean diet" and moderate wine consumption are thought to have a protective effect ("the French Paradox") due to their high content of antioxidants<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>. Antioxidants can also be taken as food additives, either as pure compounds, such as vitamins C and E and Q10, or as crude extracts, such as the fermented papaya preparation and curcumin<sup><a href="#ref-9">9</a></sup>. Using such additives succeeded in ameliorating various parameters of oxidative stress in thal, but a clear clinical benefit, such as reducing transfusion dependence, was less successful. Effective outcome may require a combination of drugs, especially those affecting both the oxidative stress and the IO.</p><p class="" id=d6442e593>A newly discovered therapeutic target is the interaction between the oxidative state and the processes of erythroid cell proliferation and differentiation, which, as mentioned above, is defective (dyserythropoiesis) in β-thal. Several agents have been tested recently, especially in murine models of β-thal intermedia (β-thal mice). Although promising, the findings of these studies need careful interpretation, given the difference in globin gene composition and erythroid differentiation between human and mouse<sup><a href="#ref-58">58</a></sup>.</p><p class="" id=d6442e600>The transcription factor forkhead box O3 (Foxo3) is a key player in the development of erythroid precursors. At early stages, it is phosphorylated by proteins of the EPOR-PI3K/AKT/mTOR pathway, translocated out of the nucleus, and remains inactivated. At late stages, it is relocated into the nucleus, gets activated, and induces the production of antioxidants that neutralize ROS to allow efficient erythropoiesis<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>.</p><p class="" id=d6442e611>In β-thal mice, Foxo3 is downregulated in late erythroid precursors owing to hyper-activation of the EPOR-PI3K/AKT/mTOR pathway, which leads to oxidative damage and ineffective erythropoiesis<sup><a href="#ref-61">61</a></sup>.</p><p class="" id=d6442e618>Rapamycin, an mTOR inhibitor, has been shown in β-thal mice to improve erythroid cell maturation, β-globin production, and anemia through Foxo3 activation<sup><a href="#ref-61">61</a></sup>. In another study, rapamycin increased γ-globin expression and HbF production in cultured erythroid precursors from β-thal intermedia patients<sup><a href="#ref-62">62</a></sup>. Another Foxo3-activating agent is resveratrol (3,5,4’-trihydroxy-trans-stilbene), a non-flavonoid polyphenol that upregulates antioxidants. The use of resveratrol in β-thal mice has been shown to increase RBC survival and Hb levels and reduce reticulocyte count<sup><a href="#ref-63">63</a></sup>. In contrast, a study in double mutant Foxo3<sup>–/–</sup>/Th3/1 mice showed that a loss of Foxo3 leads to improved early erythropoiesis<sup><a href="#ref-64">64</a></sup>.</p><p class="" id=d6442e640>Consequently, further laboratory and clinical investigations are required in this field.</p><p class="" id=d6442e643>The eukaryotic initiation factor 2 (eIF2) is a factor required for the initiation of translation through the binding of tRNA to the ribosomes. In the erythroid precursors, its activity is regulated by a mechanism involving phosphorylation at its α-subunit by heme-regulated eIF2a kinase (HRI). Stress (such as heme deficiency and oxidative stress)<sup><a href="#ref-65">65</a></sup> during the late stage of erythroid differentiation activates HRI that coordinates the syntheses of heme and globin. Furthermore, the phosphorylated α-subunit of eIF2 has been demonstrated to turn on the activating transcription factor 4 (ATF4) to diminish oxidative stress in erythroid precursors<sup><a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>.</p><p class="" id=d6442e657>This kinase has been found to be decreased in β-thal mice, leading to embryonic lethality<sup><a href="#ref-68">68</a></sup>. Salubrinal, a selective inhibitor of eIF2aP dephosphorylation, has been found to augment the HRI signaling pathway and to reduce the production of hemichromes in β-thal erythroid precursors<sup><a href="#ref-67">67</a></sup>. It has also been shown to increase HbF production with a concomitant decrease of HbA in differentiating human CD34 cells by a post-transcriptional mechanism<sup><a href="#ref-69">69</a></sup>. These findings provide the basis for manipulating the HRI-eIF2aP signaling pathway for the treatment of β-thal.</p><p class="" id=d6442e672>Peroxiredoxin-2 (Prx2) is an essential antioxidant protein that scavenges and inactivates ROS throughout erythropoiesis. It has been found to be upregulated during both murine and human β-thal<sup><a href="#ref-70">70</a></sup>. Knockout of Prx2 in β-thal mice worsened their phenotype, while administration of fused recombinant PEP1Prx2 ameliorated their symptoms, with activation of the Erk signaling pathway towards Tfr2 and the Sma and Mad (SMAD) system<sup><a href="#ref-71">71</a></sup>.</p><p class="" id=d6442e684>Heme oxygenase-1 (HO-1) is an enzyme that catalyzes the degradation of heme in response to stress, such as oxidative stress or hypoxia, both of which occur in β-thal<sup><a href="#ref-72">72</a></sup>. Its expression has been found to be augmented in EPO-dependent fetal liver erythropoietic cells from β-thal mice. Administration of tin protoporphyrin IX, an HO-1 inhibitor, improved ineffective erythropoiesis and Hb levels, and decreased spleen size and liver iron<sup><a href="#ref-73">73</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e699>Stimulation of HbF production</h2><p class="" id=d6442e702>During prenatal life in humans, the major Hb is fetal Hb (HbF), a tetramer of α- and γ-globin (α<sub>2</sub>γ<sub>2</sub>) which is replaced during the first year of life by HbA (α<sub>2</sub>β<sub>2</sub>) (Hb switching). Thus, the clinical features of β-hemoglobinopathies, including β-thal, are not apparent at birth; only as HbF levels wane are the symptoms manifested<sup><a href="#ref-74">74</a></sup>. Patients with β-thal produce high but variable levels of HbF compared to normal individuals. High levels of HbF ameliorate the severity of the disease, mainly by reducing the surplus of α-globin chains.</p><p class="" id=d6442e721>These findings have motivated the research of the mechanisms of Hb switching as well as for pharmacological and gene modification modalities to reactivate the expression of the γ-globin genes and production of HbF<sup><a href="#ref-75">75</a></sup>.</p><div class=section><a name=d6442e728 class=n-a></a><h3 class=section-title>Pharmacological approach</h3><p class="" id=d6442e733>Various compounds have been tested <i>in vitro</i> and in animal models for their capacity to reactivate the γ-globin genes<sup><a href="#ref-76">76</a></sup>. Currently, the only compound in clinical use is hydroxyurea, an S-phase cell cycle inhibitor. However, its mechanism of action on HbF remains elusive, a subset of patients are resistant, its effect in β-thal is inferior compared to that of sickle cell disease, and being myelosuppressive necessitates careful monitoring of patients<sup><a href="#ref-77">77</a></sup>.</p><p class="" id=d6442e747>New agents include those that affect chromatin regulators (such as decitabine on DNA methylation and histone deacetylase inhibitors) and others that affect DNA-binding transcription factors.</p></div><div class=section><a name=d6442e751 class=n-a></a><h3 class=section-title>Gene modification approach</h3><p class="" id=d6442e756>The patient's HSCs are subjected to gene editing <i>ex vivo</i> and then returned to the patient for reconstitution<sup><a href="#ref-78">78</a>,<a href="#ref-79">79</a></sup>.</p><p class="" id=d6442e769>Increased production of γ-globin has been accomplished using lentiviral vectors that express a zinc finger protein which interacts with the promoter of the γ-globin gene<sup><a href="#ref-80">80</a></sup> or by carrying microRNAs that silence its repressors<sup><a href="#ref-81">81</a>,<a href="#ref-82">82</a></sup>.</p><p class="" id=d6442e783>Two potent transcriptional repressors of γ-globin, BCL11A and ZBTB7A, have been identified. They act with additional <i>trans</i>-acting epigenetic repressive complexes, lineage-defining factors, and developmental programs to silence the γ-globin genes by working on <i>cis</i>-acting sequences at the globin gene loci. Inhibition of these repressors could reactivate γ-globin production in adult patients.</p><p class="" id=d6442e792>Most of the studies targeted BCL11A. Its inhibiting antisense oligonucleotides were administered in an erythroleukemia series expressing BCL11A and Krüppel-like factor 1 (KLF1)<sup><a href="#ref-83">83</a>,<a href="#ref-84">84</a></sup>. KLF1 activates the expression of the β-globin gene and it plays a role in the transcriptional silencing of the γ-globin gene, possibly through BCL11A<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>.</p><p class="" id=d6442e810>Genome editing of the promoter of BCL11A can be accomplished by several nucleases, such as engineered zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeats linked to Cas9 nucleases (CRISPR-Cas9)<sup><a href="#ref-87">87</a></sup>. It has been shown recently that ZFN-driven BCL11A enhancer ablation leads to increased production of HbF in erythroid precursors derived from β-thal HSCs, which could be used for autologous transplantation<sup><a href="#ref-88">88</a></sup>. A similar effect has been achieved with CRISPR-Cas9-mediated BCL11A enhancer inactivation in a human adult-stage erythroid cell line<sup><a href="#ref-89">89</a></sup>.</p><p class="" id=d6442e825>BCL11A has important roles in physiology; therefore, reducing its expression <i>in vivo</i> requires novel vectors that can restrict its effect to the erythroid lineage<sup><a href="#ref-82">82</a></sup>. Dissection of the erythroid-specific enhancer down to a small region in the gene offers such possibility<sup><a href="#ref-90">90</a></sup>. The same applies to other factors, like KLF1 and MYB, which are involved in HbF production.</p><p class="" id=d6442e839>One could also consider de-repressing γ-globin expression by forcing interaction of the β-locus control region with the γ-gene using a synthetic DNA-binding protein<sup><a href="#ref-91">91</a>,<a href="#ref-92">92</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e853>Gene therapy</h2><p class="" id=d6442e856>Gene therapy involves <i>in vivo</i> genetic manipulation of the autologous HSCs, which are then transplanted to the patient for reconstitution<sup><a href="#ref-78">78</a>,<a href="#ref-79">79</a></sup>. This approach has focused on two areas. (A) Increasing the production of γ-globin by the addition of its gene, overexpression of its endogenous activating transcription factors, and silencing of its repressors, as discussed above. (B) Increasing the production of β-globin by the addition of a normal gene or correction of the mutated gene. Studies of gene therapy have utilized mainly lentivirus vectors in experimental systems, including cultured CD34 HSCs from β-thal patients and β-thal mouse models. Yet the safety profile of such technologies is still uncertain.</p><p class="" id=d6442e869>From the current gene-modifying approaches, only β-globin addition has been tried in β-thal patients. Transfusion-dependent βE/β<sup>0</sup> patients have been transplanted with autologous CD34 progenitor cells transduced <i>ex vivo</i> with lentiviral β-globin vectors. To date, there are a total of seven patients who have been treated with encouraging results in terms of engraftment and transfusion independence; long-term follow up will clarify the possible insertional mutagenesis issues<sup><a href="#ref-93">93</a>,<a href="#ref-94">94</a></sup>.</p><p class="" id=d6442e885>Phase 1 clinical trials have been initiated in order to assess these issues. Early phase, open label clinical trials of LentiGlobin BB305 will assess its efficacy and safety in patients with β-thal major or sickle cell disease. Safety and tolerability of autologous CD34 HSCs transduced with TNS9.3.55 or GLOBE lentiviral vectors are also being assessed in ongoing trials. Preliminary data from the latter trial have been recently presented regarding three patients with β-thal major. All patients showed a satisfactory engraftment, with mild and reversible adverse events<sup><a href="#ref-95">95</a></sup>.</p><p class="" id=d6442e892>Genomic editing has been demonstrated to modify the β-globin gene. Thus, TALEN-mediated gene correction has been used in induced HSCs from β-thal patients<sup><a href="#ref-96">96</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e902>Allogeneic hematopoietic stem cell transplantation</h2><p class="" id=d6442e905>Allogeneic HSCT (allo-HSCT) is currently the only definitive cure for transfusion-dependent young patients before the development of IO-related tissue damage<sup><a href="#ref-97">97</a></sup>. β-thal major patients with good risk features have a &gt;90% chance of a successful outcome<sup><a href="#ref-98">98</a>,<a href="#ref-99">99</a></sup>, but allo-HSCT in high-risk patients is challenging because of graft rejection and transplant-related mortality<sup><a href="#ref-14">14</a></sup>. Novel modified or reduced-intensity conditioning regimens are being evaluated in an attempt to improve the outcome in such patients with favorable results<sup><a href="#ref-100">100</a>–<a href="#ref-102">102</a></sup>.</p><p class="" id=d6442e930>Traditionally, fully matched human leukocyte antigen (HLA)-identical siblings have been used as donors, but matched unrelated donors have also been tried in low-risk patients. Bone marrow is the preferable source of HSCs, but HSCs from the peripheral blood and cord blood are also being tried in low-risk cases.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e936>Prevention</h2><p class="" id=d6442e939>In spite of the advent of therapeutic modalities that alleviate the symptoms and may even cure the disease, the incidence of affected newborns is expected to increase. Most of the new cases are in underdeveloped countries where the standard of medical care is low and in communities where consanguinity is high. Therefore, the prevention of the homozygous state presents an important endeavor. Comprehensively preventive programs involve carrier detections, molecular diagnostics, genetic counseling, and prenatal diagnosis. Currently, prenatal diagnosis is performed, for couples at risk, by obtaining fetal material by chorionic villus sampling in the first trimester and by amniocentesis or cordocentesis in the second trimester. An additional procedure for obtaining fetal material is aspiration of celomic fluid (celocentesis) followed by selection of embryo-fetal erythroid precursors by an anti-CD71 MicroBeads method or by direct micromanipulator pickup of the cells selected on the basis of their morphology<sup><a href="#ref-103">103</a></sup>. Molecular analysis, aimed at the detection of mutations in the globin genes, is then performed<sup><a href="#ref-104">104</a></sup>.</p><p class="" id=d6442e950>Recently, the possibility of safer and cheaper prenatal diagnosis procedures emerged. Fetal-derived genetic material (cells or cell-free DNA) is obtained from the maternal blood and tested. These non-invasive procedures that present no risk to the fetus and reduce cost (no special procedures and staff are required for sampling) may allow future screening for thal as well as other genetic diseases<sup><a href="#ref-105">105</a></sup>.</p><p class="" id=d6442e957>Indeed, non-invasive prenatal testing using maternal plasma cell-free DNA has already been applied for screening for common chromosomal aneuploidies. Progress has also been made in screening for monogenic diseases, using thal as a model disease. One approach focuses on the detection or exclusion of paternally inherited fetal mutations that are absent from the mother's genome. Testing maternally inherited mutations requires highly sensitive DNA quantification. The relative mutation/haplotype dosage approach might detect fetal mutations even when the parents share the same mutation.</p><p class="" id=d6442e960>Another approach is pre-implantation genetic diagnosis of cells (usually single cells) that had been biopsied from oocytes/zygotes or embryos generated by <i>in vitro</i> fertilization. With respect to thal, this technique aims at giving birth to an unaffected newborn, and, when relevant, for cord blood cells compatible with an existing affected sibling to support HSCT. Pre-implantation diagnosis precludes the need for abortion<sup><a href="#ref-106">106</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6442e973>Conclusion</h2><p class="" id=d6442e976>Beta-thalassemia is caused by mutations in the β-globin gene, resulting in partial or complete deficiency of its product. This deficiency and the accompanying excess of the unmatched α-globin chains result in oxidative stress, dyserythropoiesis, and chronic anemia. The main therapeutic modality is blood transfusion that improves the anemia but exacerbates IO. To date, the only curative measure is allo-HSCT. New modalities, aimed at various targets, are being developed. These include the means to stimulate the synthesis of γ-globin and reduce the synthesis of α-globin, as well as the iron excess, oxidative stress, and dyserythropoiesis. Attempts to increase β-globin synthesis focus on gene manipulation. However, the most likely approach to reduce the patients' load is efficient prevention: carrier detection, prenatal diagnosis, and genetic counseling (<a href="#f1">Figure 1</a>).</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13741/ba4b3c8d-8921-4fb5-affc-f712a75ecb51_figure1.gif"><img alt="ba4b3c8d-8921-4fb5-affc-f712a75ecb51_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13741/ba4b3c8d-8921-4fb5-affc-f712a75ecb51_figure1.gif"></a><div class=caption><h3>Figure 1. Beta-thalassemia: causes, symptoms, and therapeutic modalities.</h3><p id=d6442e992>Causes and symptoms are marked in red; therapeutic modalities are marked in blue.</p></div></div></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d6442e1 class=n-a></a><h2 class=main-title id=d6752>Competing interests</h2><p class=metadata-entry><a name=d6442e105 class=n-a></a><p id=d6442e106> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d6442e1 class=n-a></a><h2 class=main-title id=d6754>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d6442e1003 class=n-a></a><h2 class=main-title id=d6442e1005>Acknowledgements</h2><p class="" id=d6442e1008>The article is in memory of Prof. Eliezer A. Rachmilewitz who recently passed away.</p></div><div class=back-section><a name=d6442e1012 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d7094>References</h2><div class="section ref-list"><a name=d6442e1012 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d6442e1019 class=n-a></a>Rund D, Rachmilewitz E: Beta-thalassemia. <i>N Engl J Med.</i> 2005; <b>353</b>(11): 1135–46. <a target=xrefwindow id=d6442e1027 href="http://www.ncbi.nlm.nih.gov/pubmed/16162884">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1030 href="http://dx.doi.org/10.1056/NEJMra050436">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d6442e1039 class=n-a></a>Clegg JB, Weatherall DJ: Thalassemia and malaria: new insights into an old problem. <i>Proc Assoc Am Physicians.</i> 1999; <b>111</b>(4): 278–82. <a target=xrefwindow id=d6442e1047 href="http://www.ncbi.nlm.nih.gov/pubmed/10417734">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1050 href="http://dx.doi.org/10.1046/j.1525-1381.1999.99235.x">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d6442e1059 class=n-a></a>Modell B, Darlison M: Global epidemiology of haemoglobin disorders and derived service indicators. <i>Bull World Health Organ.</i> 2008; <b>86</b>(6): 480–7. <a target=xrefwindow id=d6442e1067 href="http://www.ncbi.nlm.nih.gov/pubmed/18568278">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1070 href="http://dx.doi.org/10.2471/BLT.06.036673">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1073 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2647473">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d6442e1082 class=n-a></a>Kan YW, Nathan DG: Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. <i>J Clin Invest.</i> 1970; <b>49</b>(4): 635–42. <a target=xrefwindow id=d6442e1090 href="http://www.ncbi.nlm.nih.gov/pubmed/5443168">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1093 href="http://dx.doi.org/10.1172/JCI106274">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1096 href="http://www.ncbi.nlm.nih.gov/pmc/articles/322517">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d6442e1105 class=n-a></a>Porter JB, Garbowski M: The pathophysiology of transfusional iron overload. <i>Hematol Oncol Clin North Am.</i> 2014; <b>28</b>(4): 683–701, vi. <a target=xrefwindow id=d6442e1113 href="http://www.ncbi.nlm.nih.gov/pubmed/25064708">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1116 href="http://dx.doi.org/10.1016/j.hoc.2014.04.003">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d6442e1126 class=n-a></a>van de Watering L: Red cell storage and prognosis. <i>Vox Sang.</i> 2011; <b>100</b>(1): 36–45. <a target=xrefwindow id=d6442e1134 href="http://www.ncbi.nlm.nih.gov/pubmed/21175654">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1137 href="http://dx.doi.org/10.1111/j.1423-0410.2010.01441.x">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d6442e1146 class=n-a></a>Kim HO: <i>In-vitro</i> stem cell derived red blood cells for transfusion: are we there yet? <i>Yonsei Med J.</i> 2014; <b>55</b>(2): 304–9. <a target=xrefwindow id=d6442e1157 href="http://www.ncbi.nlm.nih.gov/pubmed/24532496">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1160 href="http://dx.doi.org/10.3349/ymj.2014.55.2.304">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1164 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3936641">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d6442e1173 class=n-a></a>Winslow RM: Red cell substitutes. <i>Semin Hematol.</i> 2007; <b>44</b>(1): 51–9. <a target=xrefwindow id=d6442e1181 href="http://www.ncbi.nlm.nih.gov/pubmed/17198847">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1184 href="http://dx.doi.org/10.1053/j.seminhematol.2006.09.013">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d6442e1193 class=n-a></a>Fibach E, Rachmilewitz EA: The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia. <i>Ann N Y Acad Sci.</i> 2010; <b>1202</b>: 10–6. <a target=xrefwindow id=d6442e1201 href="http://www.ncbi.nlm.nih.gov/pubmed/20712766">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1204 href="http://dx.doi.org/10.1111/j.1749-6632.2010.05577.x">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d6442e1213 class=n-a></a>Fibach E, Rachmilewitz EA: Iron overload in hematological disorders. <i>Presse Med.</i> In Press, 2017; <b>46</b>(12 Pt 2): e296–e305. <a target=xrefwindow id=d6442e1221 href="http://www.ncbi.nlm.nih.gov/pubmed/29174474">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1224 href="http://dx.doi.org/10.1016/j.lpm.2017.10.007">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d6442e1233 class=n-a></a>Hentze MW, Muckenthaler MU, Andrews NC: Balancing acts: molecular control of mammalian iron metabolism. <i>Cell.</i> 2004; <b>117</b>(3): 285–97. <a target=xrefwindow id=d6442e1241 href="http://www.ncbi.nlm.nih.gov/pubmed/15109490">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1244 href="http://dx.doi.org/10.1016/S0092-8674(04)00343-5">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d6442e1254 class=n-a></a>Hellström-Lindberg E: Management of anemia associated with myelodysplastic syndrome. <i>Semin Hematol.</i> 2005; <b>42</b>(2 Suppl 1): S10–3. <a target=xrefwindow id=d6442e1262 href="http://www.ncbi.nlm.nih.gov/pubmed/15846579">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1265 href="http://dx.doi.org/10.1053/j.seminhematol.2005.01.002">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d6442e1274 class=n-a></a>Wang J, Pantopoulos K: Regulation of cellular iron metabolism. <i>Biochem J.</i> 2011; <b>434</b>(3): 365–81. <a target=xrefwindow id=d6442e1282 href="http://www.ncbi.nlm.nih.gov/pubmed/21348856">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1285 href="http://dx.doi.org/10.1042/BJ20101825">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1288 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3048577">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d6442e1297 class=n-a></a>Breuer W, Hershko C, Cabantchik ZI: The importance of non-transferrin bound iron in disorders of iron metabolism. <i>Transfus Sci.</i> 2000; <b>23</b>(3): 185–92. <a target=xrefwindow id=d6442e1305 href="http://www.ncbi.nlm.nih.gov/pubmed/11099894">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1308 href="http://dx.doi.org/10.1016/S0955-3886(00)00087-4">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d6442e1317 class=n-a></a>Richardson DR, Ponka P: The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. <i>Biochim Biophys Acta.</i> 1997; <b>1331</b>(1): 1–40. <a target=xrefwindow id=d6442e1325 href="http://www.ncbi.nlm.nih.gov/pubmed/9325434">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1328 href="http://dx.doi.org/10.1016/S0304-4157(96)00014-7">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d6442e1337 class=n-a></a>Prus E, Fibach E: Uptake of non-transferrin iron by erythroid cells. <i>Anemia.</i> 2011; <b>2011</b>: 945289. <a target=xrefwindow id=d6442e1345 href="http://www.ncbi.nlm.nih.gov/pubmed/21490768">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1348 href="http://dx.doi.org/10.1155/2011/945289">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1351 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3065881">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d6442e1360 class=n-a></a>Konijn AM: Iron metabolism in inflammation. <i>Baillieres Clin Haematol.</i> 1994; <b>7</b>(4): 829–49. <a target=xrefwindow id=d6442e1368 href="http://www.ncbi.nlm.nih.gov/pubmed/7881156">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1371 href="http://dx.doi.org/10.1016/S0950-3536(05)80127-1">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d6442e1381 class=n-a></a>Prus E, Fibach E: The labile iron pool in human erythroid cells. <i>Br J Haematol.</i> 2008; <b>142</b>(2): 301–7. <a target=xrefwindow id=d6442e1389 href="http://www.ncbi.nlm.nih.gov/pubmed/18503586">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1392 href="http://dx.doi.org/10.1111/j.1365-2141.2008.07192.x">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d6442e1401 class=n-a></a>Jacobs A: Low molecular weight intracellular iron transport compounds. <i>Blood.</i> 1977; <b>50</b>(3): 433–9. <a target=xrefwindow id=d6442e1409 href="http://www.ncbi.nlm.nih.gov/pubmed/328083">PubMed Abstract </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d6442e1418 class=n-a></a>Jacobs A: An intracellular transit iron pool. <i>Ciba Found Symp.</i> 1976; (51): 91–106. <a target=xrefwindow id=d6442e1423 href="http://www.ncbi.nlm.nih.gov/pubmed/1052040">PubMed Abstract </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d6442e1432 class=n-a></a>Fibach E, Rachmilewitz E: The role of oxidative stress in hemolytic anemia. <i>Curr Mol Med.</i> 2008; <b>8</b>(7): 609–19. <a target=xrefwindow id=d6442e1440 href="http://www.ncbi.nlm.nih.gov/pubmed/18991647">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1443 href="http://dx.doi.org/10.2174/156652408786241384">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d6442e1452 class=n-a></a>Rombout-Sestrienkova E, van Kraaij MG, Koek GH: How we manage patients with hereditary haemochromatosis. <i>Br J Haematol.</i> 2016; <b>175</b>(5): 759–70. <a target=xrefwindow id=d6442e1460 href="http://www.ncbi.nlm.nih.gov/pubmed/27723100">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1463 href="http://dx.doi.org/10.1111/bjh.14376">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d6442e1472 class=n-a></a>Leitch HA, Fibach E, Rachmilewitz E: Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies. <i>Crit Rev Oncol Hematol.</i> 2017; <b>113</b>: 156–70. <a target=xrefwindow id=d6442e1480 href="http://www.ncbi.nlm.nih.gov/pubmed/28427505">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1483 href="http://dx.doi.org/10.1016/j.critrevonc.2017.03.002">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d6442e1493 class=n-a></a>Haghpanah S, Zarei T, Zahedi Z, <i> et al.</i>: Compliance and satisfaction with deferasirox (Exjade®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia. <i>Hematology.</i> 2014; <b>19</b>(4): 187–91. <a target=xrefwindow id=d6442e1504 href="http://www.ncbi.nlm.nih.gov/pubmed/24074344">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1507 href="http://dx.doi.org/10.1179/1607845413Y.0000000121">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727255926"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e1516 class=n-a></a>Taher AT, Origa R, Perrotta S, <i> et al.</i>: New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study. <i>Am J Hematol.</i> 2017; <b>92</b>(5): 420–8. <a target=xrefwindow id=d6442e1527 href="http://www.ncbi.nlm.nih.gov/pubmed/28142202">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1530 href="http://dx.doi.org/10.1002/ajh.24668">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727255926">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732277766"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e1543 class=n-a></a>Chuansumrit A, Songdej D, Sirachainan N, <i> et al.</i>: Safety profile of a liquid formulation of deferiprone in young children with transfusion-induced iron overload: a 1-year experience. <i>Paediatr Int Child Health.</i> 2016; <b>36</b>(3): 209–13. <a target=xrefwindow id=d6442e1554 href="http://www.ncbi.nlm.nih.gov/pubmed/26052612">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1557 href="http://dx.doi.org/10.1179/2046905515Y.0000000040">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732277766">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d6442e1570 class=n-a></a>Vlachodimitropoulou Koumoutsea E, Garbowski M, Porter J: Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization. <i>Br J Haematol.</i> 2015; <b>170</b>(6): 874–83. <a target=xrefwindow id=d6442e1578 href="http://www.ncbi.nlm.nih.gov/pubmed/26033030">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1581 href="http://dx.doi.org/10.1111/bjh.13512">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5041956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e1590 class=n-a></a>Li H, Rybicki AC, Suzuka SM, <i> et al.</i>: Transferrin therapy ameliorates disease in beta-thalassemic mice. <i>Nat Med.</i> 2010; <b>16</b>(2): 177–82. <a target=xrefwindow id=d6442e1601 href="http://www.ncbi.nlm.nih.gov/pubmed/20098432">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1604 href="http://dx.doi.org/10.1038/nm.2073">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5041956">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d6442e1617 class=n-a></a>Vinchi F, Vercellotti GM, Belcher JD, <i> et al.</i>: Elevated systemic heme and iron levels as risk factor for vascular dysfunction and atherosclerosis: Evidence from a beta-thalassemia cohort study. <i>Atherosclerosis.</i> 2017; <b>263</b>: e107–e108. <a target=xrefwindow id=d6442e1628 href="http://dx.doi.org/10.1016/j.atherosclerosis.2017.06.344">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d6442e1638 class=n-a></a>Ganz T, Nemeth E: Hepcidin and iron homeostasis. <i>Biochim Biophys Acta.</i> 2012; <b>1823</b>(9): 1434–43. <a target=xrefwindow id=d6442e1646 href="http://www.ncbi.nlm.nih.gov/pubmed/22306005">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1649 href="http://dx.doi.org/10.1016/j.bbamcr.2012.01.014">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1652 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4048856">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1065995"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e1661 class=n-a></a>Gardenghi S, Marongiu MF, Ramos P, <i> et al.</i>: Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. <i>Blood.</i> 2007; <b>109</b>(11): 5027–35. <a target=xrefwindow id=d6442e1672 href="http://www.ncbi.nlm.nih.gov/pubmed/17299088">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1675 href="http://dx.doi.org/10.1182/blood-2006-09-048868">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1679 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1885515">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1065995">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d6442e1692 class=n-a></a>De Franceschi L, Daraio F, Filippini A, <i> et al.</i>: Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. <i>Haematologica.</i> 2006; <b>91</b>(10): 1336–42. <a target=xrefwindow id=d6442e1703 href="http://www.ncbi.nlm.nih.gov/pubmed/17018382">PubMed Abstract </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d6442e1712 class=n-a></a>Tanno T, Bhanu NV, Oneal PA, <i> et al.</i>: High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. <i>Nat Med.</i> 2007; <b>13</b>(9): 1096–101. <a target=xrefwindow id=d6442e1723 href="http://www.ncbi.nlm.nih.gov/pubmed/17721544">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1726 href="http://dx.doi.org/10.1038/nm1629">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d6442e1735 class=n-a></a>Gu S, Song X, Zhao Y, <i> et al.</i>: The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes. <i>Hematology.</i> 2013; <b>18</b>(5): 286–94. <a target=xrefwindow id=d6442e1746 href="http://www.ncbi.nlm.nih.gov/pubmed/23540794">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1749 href="http://dx.doi.org/10.1179/1607845412Y.0000000064">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d6442e1758 class=n-a></a>Fertrin KY, Lanaro C, Franco-Penteado CF, <i> et al.</i>: Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15. <i>Am J Hematol.</i> 2014; <b>89</b>(4): 385–90. <a target=xrefwindow id=d6442e1769 href="http://www.ncbi.nlm.nih.gov/pubmed/24860871">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1772 href="http://dx.doi.org/10.1002/ajh.23649">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d6442e1782 class=n-a></a>Kautz L, Jung G, Valore EV, <i> et al.</i>: Identification of erythroferrone as an erythroid regulator of iron metabolism. <i>Nat Genet.</i> 2014; <b>46</b>(7): 678–84. <a target=xrefwindow id=d6442e1793 href="http://www.ncbi.nlm.nih.gov/pubmed/24880340">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1796 href="http://dx.doi.org/10.1038/ng.2996">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1800 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4104984">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d6442e1809 class=n-a></a>Choi SO, Cho YS, Kim HL, <i> et al.</i>: ROS mediate the hypoxic repression of the <i>hepcidin</i> gene by inhibiting C/EBPalpha and STAT-3. <i>Biochem Biophys Res Commun.</i> 2007; <b>356</b>(7): 312–7. <a target=xrefwindow id=d6442e1823 href="http://www.ncbi.nlm.nih.gov/pubmed/17349976">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1827 href="http://dx.doi.org/10.1016/j.bbrc.2007.02.137">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d6442e1836 class=n-a></a>Miura K, Taura K, Kodama Y, <i> et al.</i>: Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. <i>Hepatology.</i> 2008; <b>48</b>(5): 1420–9. <a target=xrefwindow id=d6442e1847 href="http://www.ncbi.nlm.nih.gov/pubmed/18671304">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1850 href="http://dx.doi.org/10.1002/hep.22486">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1097163"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e1859 class=n-a></a>Peyssonnaux C, Zinkernagel AS, Schuepbach RA, <i> et al.</i>: Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). <i>J Clin Invest.</i> 2007; <b>117</b>(7): 1926–32. <a target=xrefwindow id=d6442e1870 href="http://www.ncbi.nlm.nih.gov/pubmed/17557118">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1873 href="http://dx.doi.org/10.1172/JCI31370">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1877 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1884690">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1097163">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d6442e1890 class=n-a></a>Fraenkel PG: Anemia of Inflammation: A Review. <i>Med Clin North Am.</i> 2017; <b>101</b>(2): 285–96. <a target=xrefwindow id=d6442e1898 href="http://www.ncbi.nlm.nih.gov/pubmed/28189171">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1901 href="http://dx.doi.org/10.1016/j.mcna.2016.09.005">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1904 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5308549">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d6442e1913 class=n-a></a>Preza GC, Ruchala P, Pinon R, <i> et al.</i>: Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. <i>J Clin Invest.</i> 2011; <b>121</b>(12): 4880–8. <a target=xrefwindow id=d6442e1924 href="http://www.ncbi.nlm.nih.gov/pubmed/22045566">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1927 href="http://dx.doi.org/10.1172/JCI57693">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3225996">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717297811"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e1941 class=n-a></a>Nai A, Pagani A, Mandelli G, <i> et al.</i>: Deletion of <i>TMPRSS6</i> attenuates the phenotype in a mouse model of β-thalassemia. <i>Blood.</i> 2012; <b>119</b>(21): 5021–9. <a target=xrefwindow id=d6442e1955 href="http://www.ncbi.nlm.nih.gov/pubmed/22490684">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1959 href="http://dx.doi.org/10.1182/blood-2012-01-401885">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1962 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3426375">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717297811">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725722778"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e1975 class=n-a></a>Kautz L, Jung G, Du X, <i> et al.</i>: Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. <i>Blood.</i> 2015; <b>126</b>(17): 2031–7. <a target=xrefwindow id=d6442e1986 href="http://www.ncbi.nlm.nih.gov/pubmed/26276665">PubMed Abstract </a> | <a target=xrefwindow id=d6442e1989 href="http://dx.doi.org/10.1182/blood-2015-07-658419">Publisher Full Text </a> | <a target=xrefwindow id=d6442e1993 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4616236">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725722778">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718321375"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2006 class=n-a></a>Dussiot M, Maciel TT, Fricot A, <i> et al.</i>: An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia. <i>Nat Med.</i> 2014; <b>20</b>(4): 398–407. <a target=xrefwindow id=d6442e2017 href="http://www.ncbi.nlm.nih.gov/pubmed/24658077">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2020 href="http://dx.doi.org/10.1038/nm.3468">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718321375">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d6442e2033 class=n-a></a>Motta I, Scaramellini N, Cappellini MD: Investigational drugs in phase I and phase II clinical trials for thalassemia. <i>Expert Opin Investig Drugs.</i> 2017; <b>26</b>(7): 793–802. <a target=xrefwindow id=d6442e2041 href="http://www.ncbi.nlm.nih.gov/pubmed/28540737">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2044 href="http://dx.doi.org/10.1080/13543784.2017.1335709">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d6442e2053 class=n-a></a>Libani IV, Guy EC, Melchiori L, <i> et al.</i>: Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia. <i>Blood.</i> 2008; <b>112</b>(3): 875–85. <a target=xrefwindow id=d6442e2064 href="http://www.ncbi.nlm.nih.gov/pubmed/18480424">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2067 href="http://dx.doi.org/10.1182/blood-2007-12-126938">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2071 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2481539">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d6442e2080 class=n-a></a>Savona MR: Are we altering the natural history of primary myelofibrosis? <i>Leuk Res.</i> 2014; <b>38</b>(9): 1004–12. <a target=xrefwindow id=d6442e2088 href="http://www.ncbi.nlm.nih.gov/pubmed/24931396">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2091 href="http://dx.doi.org/10.1016/j.leukres.2014.04.012">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d6442e2101 class=n-a></a>Casu C, Oikonomidou PR, Lo Presti V, <i> et al.</i>: POTENTIAL THERAPEUTIC APPLICATIONS OF JAK2 INHIBITORS AND HIF2a-ASO FOR THE TREATMENT OF beta-THALASSEMIA INTERMEDIA AND MAJOR. <i>Am J Hematol.</i> 2017; <b>92</b>: E221–E221.</span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d6442e2119 class=n-a></a>Walters RW, Parker R: Coupling of Ribostasis and Proteostasis: Hsp70 Proteins in mRNA Metabolism. <i>Trends Biochem Sci.</i> 2015; <b>40</b>(10): 552–9. <a target=xrefwindow id=d6442e2127 href="http://www.ncbi.nlm.nih.gov/pubmed/26410596">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2130 href="http://dx.doi.org/10.1016/j.tibs.2015.08.004">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2133 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4584423">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d6442e2142 class=n-a></a>Ribeil J, Zermati Y, Vandekerckhove J, <i> et al.</i>: Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. <i>Nature.</i> 2007; <b>445</b>(7123): 102–5. <a target=xrefwindow id=d6442e2153 href="http://www.ncbi.nlm.nih.gov/pubmed/17167422">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2156 href="http://dx.doi.org/10.1038/nature05378">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718544629"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2165 class=n-a></a>Arlet JB, Ribeil JA, Guillem F, <i> et al.</i>: HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia. <i>Nature.</i> 2014; <b>514</b>(7521): 242–6. <a target=xrefwindow id=d6442e2176 href="http://www.ncbi.nlm.nih.gov/pubmed/25156257">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2179 href="http://dx.doi.org/10.1038/nature13614">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718544629">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d6442e2192 class=n-a></a>Guillem F, Dussiot M, Causse S, <i> et al.</i>: XPO1 (Exportin-1) Is a Major Regulator of Human Erythroid Differentiation. Potential Clinical Applications to Decrease Ineffective Erythropoiesis of Beta-Thalassemia. <i>Blood.</i> 2015; <b>126</b>(23): 2368. <a target=xrefwindow id=d6442e2203 href="http://www.bloodjournal.org/content/126/23/2368?sso-checked=true">Reference Source</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d6442e2212 class=n-a></a>Quek L, Thein SL: Molecular therapies in beta-thalassaemia. <i>Br J Haematol.</i> 2007; <b>136</b>(3): 353–65. <a target=xrefwindow id=d6442e2220 href="http://www.ncbi.nlm.nih.gov/pubmed/17129232">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2223 href="http://dx.doi.org/10.1111/j.1365-2141.2006.06408.x">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d6442e2233 class=n-a></a>Mettananda S, Gibbons RJ, Higgs DR: Understanding α-globin gene regulation and implications for the treatment of β-thalassemia. <i>Ann N Y Acad Sci.</i> 2016; <b>1368</b>(1): 16–24. <a target=xrefwindow id=d6442e2241 href="http://www.ncbi.nlm.nih.gov/pubmed/26695885">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2244 href="http://dx.doi.org/10.1111/nyas.12988">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726932535"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2253 class=n-a></a>Mettananda S, Fisher CA, Sloane-Stanley JA, <i> et al.</i>: Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia. <i>Haematologica.</i> 2017; <b>102</b>(3): e80–e84. <a target=xrefwindow id=d6442e2264 href="http://www.ncbi.nlm.nih.gov/pubmed/27810991">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2267 href="http://dx.doi.org/10.3324/haematol.2016.155655">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2271 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5394973">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726932535">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d6442e2284 class=n-a></a>Khemayanto H, Shi B: Role of Mediterranean diet in prevention and management of type 2 diabetes. <i>Chin Med J (Engl).</i> 2014; <b>127</b>(20): 3651–6. <a target=xrefwindow id=d6442e2292 href="http://www.ncbi.nlm.nih.gov/pubmed/25316244">PubMed Abstract </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728866185"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2301 class=n-a></a>Hu X, Wang H, Lv X, <i> et al.</i>: Cardioprotective Effects of Tannic Acid on Isoproterenol-Induced Myocardial Injury in Rats: Further Insight into 'French Paradox'. <i>Phytother Res.</i> 2015; <b>29</b>(9): 1295–1303. <a target=xrefwindow id=d6442e2312 href="http://www.ncbi.nlm.nih.gov/pubmed/25989747">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2315 href="http://dx.doi.org/10.1002/ptr.5376">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728866185">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d6442e2328 class=n-a></a>Bank A: Regulation of human fetal hemoglobin: new players, new complexities. <i>Blood.</i> 2006; <b>107</b>(2): 435–43. <a target=xrefwindow id=d6442e2336 href="http://www.ncbi.nlm.nih.gov/pubmed/16109777">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2339 href="http://dx.doi.org/10.1182/blood-2005-05-2113">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2342 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1895603">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1098828"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2351 class=n-a></a>Marinkovic D, Zhang X, Yalcin S, <i> et al.</i>: Foxo3 is required for the regulation of oxidative stress in erythropoiesis. <i>J Clin Invest.</i> 2007; <b>117</b>(8): 2133–44. <a target=xrefwindow id=d6442e2362 href="http://www.ncbi.nlm.nih.gov/pubmed/17671650">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2365 href="http://dx.doi.org/10.1172/JCI31807">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1934587">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1098828">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725422558"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2383 class=n-a></a>Wang H, Li Y, Wang S, <i> et al.</i>: Knockdown of transcription factor forkhead box O3 (FOXO3) suppresses erythroid differentiation in human cells and zebrafish. <i>Biochem Biophys Res Commun.</i> 2015; <b>460</b>(4): 923–30. <a target=xrefwindow id=d6442e2394 href="http://www.ncbi.nlm.nih.gov/pubmed/25843800">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2397 href="http://dx.doi.org/10.1016/j.bbrc.2015.03.128">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725422558">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718469535"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2410 class=n-a></a>Zhang X, Campreciós G, Rimmelé P, <i> et al.</i>: FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis. <i>Am J Hematol.</i> 2014; <b>89</b>(10): 954–63. <a target=xrefwindow id=d6442e2421 href="http://www.ncbi.nlm.nih.gov/pubmed/24966026">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2424 href="http://dx.doi.org/10.1002/ajh.23786">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2428 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4201594">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718469535">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730503347"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2441 class=n-a></a>Pecoraro A, Troia A, Calzolari R, <i> et al.</i>: Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients. <i>Hemoglobin.</i> 2015; <b>39</b>(4): 225–9. <a target=xrefwindow id=d6442e2452 href="http://www.ncbi.nlm.nih.gov/pubmed/26016899">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2455 href="http://dx.doi.org/10.3109/03630269.2015.1036882">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730503347">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718085522"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2468 class=n-a></a>Franco SS, De Falco L, Ghaffari S, <i> et al.</i>: Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice. <i>Haematologica.</i> 2014; <b>99</b>(2): 267–75. <a target=xrefwindow id=d6442e2479 href="http://www.ncbi.nlm.nih.gov/pubmed/23975182">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2482 href="http://dx.doi.org/10.3324/haematol.2013.090076">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2486 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3912956">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718085522">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d6442e2499 class=n-a></a>Liang R, Campreciós G, Bigarella C, <i> et al.</i>: Loss of Foxo3 reduces erythroblast apoptosis and enhances RBC production in beta-thalassemic mice. <i>Blood.</i> 2015; <b>126</b>(23): 756. <a target=xrefwindow id=d6442e2510 href="http://www.bloodjournal.org/content/126/23/756?sso-checked=true">Reference Source</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d6442e2519 class=n-a></a>Donnelly N, Gorman AM, Gupta S, <i> et al.</i>: The eIF2α kinases: their structures and functions. <i>Cell Mol Life Sci.</i> 2013; <b>70</b>(19): 3493–511. <a target=xrefwindow id=d6442e2530 href="http://www.ncbi.nlm.nih.gov/pubmed/23354059">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2533 href="http://dx.doi.org/10.1007/s00018-012-1252-6">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d6442e2543 class=n-a></a>Chen JJ: Translational control by heme-regulated eIF2α kinase during erythropoiesis. <i>Curr Opin Hematol.</i> 2014; <b>21</b>(3): 172–8. <a target=xrefwindow id=d6442e2551 href="http://www.ncbi.nlm.nih.gov/pubmed/24714526">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2554 href="http://dx.doi.org/10.1097/MOH.0000000000000030">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2557 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4124034">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d6442e2566 class=n-a></a>Suragani RN, Zachariah RS, Velazquez JG, <i> et al.</i>: Heme-regulated eIF2α kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis. <i>Blood.</i> 2012; <b>119</b>(22): 5276–84. <a target=xrefwindow id=d6442e2577 href="http://www.ncbi.nlm.nih.gov/pubmed/22498744">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2580 href="http://dx.doi.org/10.1182/blood-2011-10-388132">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2584 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3369616">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d6442e2593 class=n-a></a>Han AP, Fleming MD, Chen JJ: Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. <i>J Clin Invest.</i> 2005; <b>115</b>(6): 1562–70. <a target=xrefwindow id=d6442e2601 href="http://www.ncbi.nlm.nih.gov/pubmed/15931390">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2604 href="http://dx.doi.org/10.1172/JCI24141">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2607 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1136998">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718549268"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2616 class=n-a></a>Hahn CK, Lowrey CH: Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA. <i>Blood.</i> 2014; <b>124</b>(17): 2730–4. <a target=xrefwindow id=d6442e2624 href="http://www.ncbi.nlm.nih.gov/pubmed/25170120">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2627 href="http://dx.doi.org/10.1182/blood-2014-03-564302">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2630 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4208286">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718549268">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d6442e2643 class=n-a></a>De Franceschi L, Bertoldi M, De Falco L, <i> et al.</i>: Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic erythropoiesis. <i>Haematologica.</i> 2011; <b>96</b>(11): 1595–604. <a target=xrefwindow id=d6442e2654 href="http://www.ncbi.nlm.nih.gov/pubmed/21750082">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2657 href="http://dx.doi.org/10.3324/haematol.2011.043612">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2661 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3208676">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725548201"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2670 class=n-a></a>Matte A, De Falco L, Iolascon A, <i> et al.</i>: The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis. <i>Antioxid Redox Signal.</i> 2015; <b>23</b>(16): 1284–97. <a target=xrefwindow id=d6442e2681 href="http://www.ncbi.nlm.nih.gov/pubmed/26058667">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2684 href="http://dx.doi.org/10.1089/ars.2014.6237">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2688 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4677567">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725548201">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d6442e2702 class=n-a></a>Pittalà V, Salerno L, Romeo G, <i> et al.</i>: A focus on heme oxygenase-1 (HO-1) inhibitors. <i>Curr Med Chem.</i> 2013; <b>20</b>(30): 3711–32. <a target=xrefwindow id=d6442e2713 href="http://www.ncbi.nlm.nih.gov/pubmed/23746277">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2716 href="http://dx.doi.org/10.2174/0929867311320300003">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d6442e2725 class=n-a></a>Santos DG, Mikhael M, Rivella S, <i> et al.</i>: Heme Oxygenase 1 Plays a Role In The Pathophysiology Of beta-Thalassemia. <i>Blood.</i> 2015; 122.</span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d6442e2740 class=n-a></a>Weatherall DJ: Mechanisms for the heterogeneity of the thalassemias. <i>IJPHO.</i> 1997; <b>4</b>: 3–10. <a target=xrefwindow id=d6442e2748 href="http://serials.unibo.it/cgi-ser/start/en/spogli/df-s.tcl?prog_art=536709&amp;language=ENGLISH&amp;view=articoli">Reference Source</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d6442e2757 class=n-a></a>Sripichai O, Fucharoen S: Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches. <i>Expert Rev Hematol.</i> 2016; <b>9</b>(12): 1129–37. <a target=xrefwindow id=d6442e2765 href="http://www.ncbi.nlm.nih.gov/pubmed/27801605">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2768 href="http://dx.doi.org/10.1080/17474086.2016.1255142">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d6442e2777 class=n-a></a>Gambari R, Fibach E: Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia. <i>Curr Med Chem.</i> 2007; <b>14</b>(2): 199–212. <a target=xrefwindow id=d6442e2785 href="http://www.ncbi.nlm.nih.gov/pubmed/17266579">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2788 href="http://dx.doi.org/10.2174/092986707779313318">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717995564"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2797 class=n-a></a>Fucharoen S, Inati A, Siritanaratku N, <i> et al.</i>: A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia. <i>Br J Haematol.</i> 2013; <b>161</b>(4): 587–93. <a target=xrefwindow id=d6442e2808 href="http://www.ncbi.nlm.nih.gov/pubmed/23530969">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2811 href="http://dx.doi.org/10.1111/bjh.12304">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2815 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3970579">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717995564">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d6442e2829 class=n-a></a>Smith EC, Orkin SH: Hemoglobin genetics: recent contributions of GWAS and gene editing. <i>Hum Mol Genet.</i> 2016; <b>25</b>(R2): R99–R105. <a target=xrefwindow id=d6442e2837 href="http://www.ncbi.nlm.nih.gov/pubmed/27340226">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2840 href="http://dx.doi.org/10.1093/hmg/ddw170">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2843 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5036874">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d6442e2852 class=n-a></a>Wilber A, Hargrove PW, Kim YS, <i> et al.</i>: Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34<sup>+</sup> cells after lentiviral vector-mediated gene transfer. <i>Blood.</i> 2011; <b>117</b>(10): 2817–26. <a target=xrefwindow id=d6442e2866 href="http://www.ncbi.nlm.nih.gov/pubmed/21156846">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2870 href="http://dx.doi.org/10.1182/blood-2010-08-300723">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2873 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3062294">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d6442e2882 class=n-a></a>Costa FC, Fedosyuk H, Chazelle AM, <i> et al.</i>: Mi2β is required for γ-globin gene silencing: temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in β-YAC transgenic mice. <i>PLoS Genet.</i> 2012; <b>8</b>(12): e1003155. <a target=xrefwindow id=d6442e2893 href="http://www.ncbi.nlm.nih.gov/pubmed/23284307">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2896 href="http://dx.doi.org/10.1371/journal.pgen.1003155">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2900 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3527334">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724138500"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2909 class=n-a></a>Lulli V, Romania P, Morsilli O, <i> et al.</i>: MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A. <i>PLoS One.</i> 2013; <b>8</b>(4): e60436. <a target=xrefwindow id=d6442e2920 href="http://www.ncbi.nlm.nih.gov/pubmed/23593217">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2923 href="http://dx.doi.org/10.1371/journal.pone.0060436">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2927 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3617093">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724138500">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725567224"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e2940 class=n-a></a>Guda S, Brendel C, Renella R, <i> et al.</i>: miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction. <i>Mol Ther.</i> 2015; <b>23</b>(9): 1465–74. <a target=xrefwindow id=d6442e2951 href="http://www.ncbi.nlm.nih.gov/pubmed/26080908">PubMed Abstract </a> | <a target=xrefwindow id=d6442e2954 href="http://dx.doi.org/10.1038/mt.2015.113">Publisher Full Text </a> | <a target=xrefwindow id=d6442e2958 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4817887">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725567224">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d6442e2971 class=n-a></a>Guo SL, Aghajan M, Casu C, <i> et al.</i>: Targeting TMPRSS6 Using Antisense Technology for the Treatment of Beta-Thalassemia. <i>Blood.</i> 2015; <b>126</b>(23): 753. <a target=xrefwindow id=d6442e2982 href="http://www.bloodjournal.org/content/126/23/753">Reference Source</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d6442e2992 class=n-a></a>Peralta R, Low A, Kim A, <i> et al.</i>: Targeting BCL11A and KLF1 For The Treatment Of Sickle Cell Disease and beta-Thalassemia <i>In Vitro</i> using Antisense Oligonucleotides. <i>Blood.</i> 2013; <b>122</b>(21): 1022. <a target=xrefwindow id=d6442e3006 href="http://www.bloodjournal.org/content/122/21/1022">Reference Source</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d6442e3015 class=n-a></a>Tallack MR, Perkins AC: KLF1 directly coordinates almost all aspects of terminal erythroid differentiation. <i>IUBMB Life.</i> 2010; <b>62</b>(12): 886–90. <a target=xrefwindow id=d6442e3023 href="http://www.ncbi.nlm.nih.gov/pubmed/21190291">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3026 href="http://dx.doi.org/10.1002/iub.404">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d6442e3035 class=n-a></a>Esteghamat F, Gillemans N, Bilic I, <i> et al.</i>: Erythropoiesis and globin switching in compound <i>Klf1::Bcl11a</i> mutant mice. <i>Blood.</i> 2013; <b>121</b>(13): 2553–62. <a target=xrefwindow id=d6442e3049 href="http://www.ncbi.nlm.nih.gov/pubmed/23361909">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3053 href="http://dx.doi.org/10.1182/blood-2012-06-434530">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d6442e3062 class=n-a></a>McNutt M: Breakthrough to genome editing. <i>Science.</i> 2015; <b>350</b>(6267): 1445. <a target=xrefwindow id=d6442e3070 href="http://www.ncbi.nlm.nih.gov/pubmed/26680163">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3073 href="http://dx.doi.org/10.1126/science.aae0479">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732277784"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e3082 class=n-a></a>Reik A, Chang K, Vierstra J, <i> et al.</i>: 53. From GWAS To the Clinic: Genome-Editing the Human BCL11A Erythroid Enhancer for Fetal Globin Elevation in the Hemoglobinopathies. <i>Molecular Therapy.</i> 2015; <b>23</b>(Supplement 1): S23–S24. <a target=xrefwindow id=d6442e3093 href="http://dx.doi.org/10.1016/S1525-0016(16)33658-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732277784">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d6442e3106 class=n-a></a>Bauer DE, Canver MC, Smith EC, <i> et al.</i>: Crispr-Cas9 Saturating Mutagenesis Reveals an Achilles Heel in the <i>BCL11A</i> Erythroid Enhancer for Fetal Hemoglobin Induction (by Genome Editing). <i>Blood.</i> 2015; <b>126</b>(23): 638. <a target=xrefwindow id=d6442e3120 href="http://www.bloodjournal.org/content/126/23/638?sso-checked=true">Reference Source</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725753021"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e3130 class=n-a></a>Vierstra J, Reik A, Chang K, <i> et al.</i>: Functional footprinting of regulatory DNA. <i>Nat Methods.</i> 2015; <b>12</b>(10): 927–30. <a target=xrefwindow id=d6442e3141 href="http://www.ncbi.nlm.nih.gov/pubmed/26322838">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3144 href="http://dx.doi.org/10.1038/nmeth.3554">Publisher Full Text </a> | <a target=xrefwindow id=d6442e3148 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5381659">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725753021">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726502183"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e3161 class=n-a></a>Breda L, Motta I, Lourenco S, <i> et al.</i>: Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers. <i>Blood.</i> 2016; <b>128</b>(8): 1139–43. <a target=xrefwindow id=d6442e3172 href="http://www.ncbi.nlm.nih.gov/pubmed/27405777">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3175 href="http://dx.doi.org/10.1182/blood-2016-01-691089">Publisher Full Text </a> | <a target=xrefwindow id=d6442e3179 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5000846">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726502183">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718533394"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e3192 class=n-a></a>Deng W, Rupon JW, Krivega I, <i> et al.</i>: Reactivation of developmentally silenced globin genes by forced chromatin looping. <i>Cell.</i> 2014; <b>158</b>(4): 849–60. <a target=xrefwindow id=d6442e3203 href="http://www.ncbi.nlm.nih.gov/pubmed/25126789">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3206 href="http://dx.doi.org/10.1016/j.cell.2014.05.050">Publisher Full Text </a> | <a target=xrefwindow id=d6442e3210 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4134511">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718533394">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d6442e3223 class=n-a></a>Cavazzana M, Ribeil JA, Payen E, <i> et al.</i>: Outcomes of Gene Therapy for Severe Sickle Disease and Beta-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced <i>Ex Vivo</i> with a Lentiviral Beta AT87Q-Globin Vector. <i>Blood.</i> 2015; <b>126</b>(23): 202. <a target=xrefwindow id=d6442e3237 href="http://www.bloodjournal.org/content/126/23/202">Reference Source</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d6442e3246 class=n-a></a>Walters MC, Rasko J, Hongeng S, <i> et al.</i>: Update of Results from the Northstar Study (HGB-204): A Phase 1/2 Study of Gene Therapy for Beta-Thalassemia Major Via Transplantation of Autologous Hematopoietic Stem Cells Transduced <i>Ex-Vivo</i> with a Lentiviral Beta AT87Q-Globin Vector (LentiGlobin BB305 Drug Product). <i>Blood.</i> 2015; <b>126</b>(23): 201. <a target=xrefwindow id=d6442e3260 href="http://www.bloodjournal.org/content/126/23/201">Reference Source</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d6442e3269 class=n-a></a>Marktel S, Giglio F, Cicalese MP, <i> et al.</i>: A Phase I/Ii Study of Autologous Hematopoietic Stem Cells Genetically Modified with Globe Lentiviral Vector for the Treatment of Transfusion Dependent Beta-Thalassemia. <i>Haematologica.</i> 2016; <b>101</b>: 168–168.</span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d6442e3288 class=n-a></a>Ma N, Liao B, Zhang H, <i> et al.</i>: Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells. <i>J Biol Chem.</i> 2013; <b>288</b>(48): 34671–9. <a target=xrefwindow id=d6442e3299 href="http://www.ncbi.nlm.nih.gov/pubmed/24155235">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3302 href="http://dx.doi.org/10.1074/jbc.M113.496174">Publisher Full Text </a> | <a target=xrefwindow id=d6442e3306 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3843079">Free Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d6442e3315 class=n-a></a>Lucarelli G, Isgrò A, Sodani P, <i> et al.</i>: Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. <i>Cold Spring Harb Perspect Med.</i> 2012; <b>2</b>(5): a011825. <a target=xrefwindow id=d6442e3326 href="http://www.ncbi.nlm.nih.gov/pubmed/22553502">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3329 href="http://dx.doi.org/10.1101/cshperspect.a011825">Publisher Full Text </a> | <a target=xrefwindow id=d6442e3333 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3331690">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718371844"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e3342 class=n-a></a>Angelucci E, Matthes-Martin S, Baronciani D, <i> et al.</i>: Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. <i>Haematologica.</i> 2014; <b>99</b>(5): 811–20. <a target=xrefwindow id=d6442e3353 href="http://www.ncbi.nlm.nih.gov/pubmed/24790059">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3356 href="http://dx.doi.org/10.3324/haematol.2013.099747">Publisher Full Text </a> | <a target=xrefwindow id=d6442e3360 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4008115">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718371844">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d6442e3373 class=n-a></a>Goussetis E, Peristeri I, Kitra V, <i> et al.</i>: HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience. <i>Bone Marrow Transplant.</i> 2012; <b>47</b>(8): 1061–6. <a target=xrefwindow id=d6442e3384 href="http://www.ncbi.nlm.nih.gov/pubmed/22080966">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3387 href="http://dx.doi.org/10.1038/bmt.2011.219">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d6442e3396 class=n-a></a>Gaziev J, De Angelis G, Isgro A, <i> et al.</i>: Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients. <i>Blood.</i> 2015; <b>126</b>: 620. <a target=xrefwindow id=d6442e3407 href="http://www.bloodjournal.org/content/126/23/620">Reference Source</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727353028"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6442e3416 class=n-a></a>King AA, Kamani N, Bunin N, <i> et al.</i>: Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies. <i>Am J Hematol.</i> 2015; <b>90</b>(12): 1093–8. <a target=xrefwindow id=d6442e3427 href="http://www.ncbi.nlm.nih.gov/pubmed/26348869">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3430 href="http://dx.doi.org/10.1002/ajh.24183">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727353028">F1000 Recommendation</a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d6442e3444 class=n-a></a>Mohanan EP, Panetta JC, Royan SSB, <i> et al.</i>: Population Pharmacokinetics of Fludarabine and Treosulfan in Patients with Thalassemia Undergoing Hematopoietic Stem Cell Transplantation. <i>Blood.</i> 2015; <b>126</b>(23): 3120. <a target=xrefwindow id=d6442e3455 href="http://www.bloodjournal.org/content/126/23/3120?sso-checked=true">Reference Source</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d6442e3464 class=n-a></a>Giambona A, Leto F, Damiani G, <i> et al.</i>: Identification of embryo-fetal cells in celomic fluid using morphological and short-tandem repeats analysis. <i>Prenat Diagn.</i> 2016; <b>36</b>(10): 973–978. <a target=xrefwindow id=d6442e3475 href="http://www.ncbi.nlm.nih.gov/pubmed/27592841">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3478 href="http://dx.doi.org/10.1002/pd.4922">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d6442e3487 class=n-a></a>Li DZ, Yang YD: Invasive prenatal diagnosis of fetal thalassemia. <i>Best Pract Res Clin Obstet Gynaecol.</i> 2017; <b>39</b>: 41–52. <a target=xrefwindow id=d6442e3495 href="http://www.ncbi.nlm.nih.gov/pubmed/27889305">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3498 href="http://dx.doi.org/10.1016/j.bpobgyn.2016.10.011">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d6442e3507 class=n-a></a>Hudecova I, Chiu RW: Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA. <i>Best Pract Res Clin Obstet Gynaecol.</i> 2017; <b>39</b>: 63–73. <a target=xrefwindow id=d6442e3515 href="http://www.ncbi.nlm.nih.gov/pubmed/27887921">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3518 href="http://dx.doi.org/10.1016/j.bpobgyn.2016.10.016">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d6442e3527 class=n-a></a>Traeger-Synodinos J: Pre-implantation genetic diagnosis. <i>Best Pract Res Clin Obstet Gynaecol.</i> 2017; <b>39</b>: 74–88. <a target=xrefwindow id=d6442e3535 href="http://www.ncbi.nlm.nih.gov/pubmed/27856159">PubMed Abstract </a> | <a target=xrefwindow id=d6442e3538 href="http://dx.doi.org/10.1016/j.bpobgyn.2016.10.010">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2156.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2156.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Hematology, Hadassah &ndash; Hebrew University Medical Center, Jerusalem, Israel<br/> <sup>2</sup> Department of Hematology, The Edith Wolfson Medical Center, Holon, Israel<br/> <p> <div class=margin-bottom> Eitan Fibach <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Eliezer A. Rachmilewitz <br/> <span>Roles: </span> Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2156/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 20 Dec 2017, 6:2156 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12688.1">https://doi.org/10.12688/f1000research.12688.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Fibach E and Rachmilewitz EA. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13741 data-id=12688 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12688.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2156/v1/pdf?article_uuid=d31e704d-3611-44c1-9683-68564845baf1" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12688.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Fibach E and Rachmilewitz EA. Pathophysiology and treatment of patients with beta-thalassemia – an update [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2156 (<a href="https://doi.org/10.12688/f1000research.12688.1" target=_blank>https://doi.org/10.12688/f1000research.12688.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12688 id=mobile-track-article-signin-12688 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12688?target=/articles/6-2156.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13741 /> <input name=articleId type=hidden value=12688 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Ali Taher</strong>, American University of Beirut Medical Center, Lebanon </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Aurelio Maggio</strong>, Division of Haematology II, Villa Sofia-Cervello Hospital, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2156.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2156.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28997-29001></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28998-29002></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2156/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>20 Dec 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ali Taher</strong>, American University of Beirut Medical Center, Lebanon </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Aurelio Maggio</strong>, Division of Haematology II, Villa Sofia-Cervello Hospital, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2156.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2156/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Pathophysiology and treatment of patients...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2156/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2156/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2156/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Fibach E and Rachmilewitz EA');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2156/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2156",
            templates : {
                twitter : "Pathophysiology and treatment of patients with beta-thalassemia.... Fibach E and Rachmilewitz EA, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2156/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Pathophysiology and treatment of patients with beta-thalassemia \u2013 an update", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Pathophysiology and treatment of patients with beta-thalassemia \u2013 an update", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12688/13741")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13741");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "29001": 0,
                           "29002": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "fab37fc7-a092-4c1b-a608-bb214f257757";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2156.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2156.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2156.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2156.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2156.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>